Search Browse Earnings

Lucid Diagnostics Inc.

Nasdaq:LUCD

Surgical & Medical Instruments & Apparatus·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Lucid Diagnostics Inc. — SlamSEC

CEO

Aklog Lishan

Revenue

$2.4M

+544.0% YoY

FY 2024

Adj. EBITDA

-$46.0M

-1893.9% margin

FY 2024

Net Income

-$52.7M

-2169.1% margin

FY 2024

EPS (Diluted)

-$1.26

FY 2024

Stock Price

$1.40

-0.4%

2026-03-06

52W Range

$0.95 – $1.80

P/E Ratio

-1.1x

Market Cap

$192.5M

Cash

$18.9M

FY 2024

Total Debt

—

Net Cash

$18.9M

FY 2024

Enterprise Value

$173.6M

Debt / EBITDA

0.4x

FY 2024

EV / EBITDA

-3.8x

Employees

—